| Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label … D Sibbing, D Aradi, C Jacobshagen, L Gross, D Trenk, T Geisler, M Orban, ... The Lancet 390 (10104), 1747-1757, 2017 | 579 | 2017 |
| Meta-analysis of cell therapy studies in heart failure and acute myocardial infarction M Gyöngyösi, PM Haller, DJ Blake, E Martin Rendon Circulation research 123 (2), 301-308, 2018 | 95 | 2018 |
| Clinical application of the 4th Universal Definition of Myocardial Infarction TS Hartikainen, NA Sörensen, PM Haller, A Goßling, J Lehmacher, ... European heart journal 41 (23), 2209-2216, 2020 | 83 | 2020 |
| Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis PM Haller, P Sulzgruber, C Kaufmann, B Geelhoed, J Tamargo, ... European Heart Journal-Cardiovascular Pharmacotherapy 5 (4), 226-236, 2019 | 44 | 2019 |
| Remote ischemic perconditioning attenuates adverse cardiac remodeling and preserves left ventricular function in a rat model of reperfused myocardial infarction PM Pilz, O Hamza, O Gidlöf, IF Gonçalves, EV Tretter, S Trojanek, ... International Journal of Cardiology 285, 72-79, 2019 | 42 | 2019 |
| Impact of age on short-and long-term mortality of patients with ST-elevation myocardial infarction in the VIENNA STEMI network PM Haller, B Jäger, S Farhan, G Christ, W Schreiber, F Weidinger, ... Wiener klinische Wochenschrift 130, 172-181, 2018 | 35 | 2018 |
| A biomarker model to distinguish types of myocardial infarction and injury JT Neumann, J Weimann, NA Sörensen, TS Hartikainen, PM Haller, ... Journal of the American College of Cardiology 78 (8), 781-790, 2021 | 29 | 2021 |
| Performance of the ESC 0/1-h and 0/3-h algorithm for the rapid identification of myocardial infarction without ST-elevation in patients with diabetes PM Haller, J Boeddinghaus, JT Neumann, NA Sörensen, TS Hartikainen, ... Diabetes Care 43 (2), 460-467, 2020 | 25 | 2020 |
| MicroRNAs as regulators and biomarkers of platelet function and activity in coronary artery disease A Nossent, P Haller, B Jäger, K Vargas, J Wojta, K Huber, D Baek, J Villén, ... Thrombosis and Haemostasis 119 (10), 1563-1572, 2019 | 25 | 2019 |
| Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis KG Vargas, PM Haller, B Jaeger, M Tscharre, RK Binder, C Mueller, ... Clinical Research in Cardiology 108, 749-762, 2019 | 23 | 2019 |
| Predictive value of serial ECGs in patients with suspected myocardial infarction J Lehmacher, JT Neumann, NA Sörensen, A Goßling, PM Haller, ... Journal of clinical medicine 9 (7), 2303, 2020 | 20 | 2020 |
| Predictors of transportation delay in patients with suspected ST-elevation-myocardial infarction in the VIENNA-STEMI network B Jäger, PM Haller, E Piackova, A Kaff, G Christ, W Schreiber, ... Clinical Research in Cardiology 109, 393-399, 2020 | 20 | 2020 |
| Prognostic value of a novel and established high-sensitivity troponin I assay in patients presenting with suspected myocardial infarction NA Sörensen, S Ludwig, N Makarova, JT Neumann, J Lehmacher, ... Biomolecules 9 (9), 469, 2019 | 20 | 2019 |
| Diurnal variability of on-treatment platelet reactivity in clopidogrel versus prasugrel treated acute coronary syndrome patients: a pre-specified TROPICAL-ACS sub-study MK Freynhofer, R Hein-Rothweiler, PM Haller, D Aradi, DA Dezsi, L Gross, ... Thrombosis and Haemostasis 119 (04), 660-667, 2019 | 18 | 2019 |
| Course of platelet miRNAs after cessation of P2Y12 antagonists B Jäger, S Stojkovic, PM Haller, E Piackova, BS Kahl, T Andric, ... European Journal of Clinical Investigation 49 (8), e13149, 2019 | 17 | 2019 |
| Role of cardiac biomarkers in epidemiology and risk outcomes PM Haller, BN Beer, AM Tonkin, S Blankenberg, JT Neumann Clinical Chemistry 67 (1), 96-106, 2021 | 16 | 2021 |
| Changes in circulating extracellular vesicles in patients with st-elevation myocardial infarction and potential effects of remote ischemic conditioning—A randomized controlled … PM Haller, B Jäger, E Piackova, L Sztulman, C Wegberger, J Wojta, ... Biomedicines 8 (7), 218, 2020 | 16 | 2020 |
| Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomised trials PM Haller, KG Vargas, MC Haller, E Piackova, J Wojta, M Gyöngyösi, ... European Heart Journal: Acute Cardiovascular Care 9 (1_suppl), 82-92, 2020 | 16 | 2020 |
| Diagnostic validation of a high-sensitivity cardiac troponin I assay NA Sörensen, A Goßling, JT Neumann, TS Hartikainen, PM Haller, ... Clinical Chemistry 67 (9), 1230-1239, 2021 | 14 | 2021 |
| Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy B Jäger, E Piackova, PM Haller, T Andric, B Kahl, G Christ, A Geppert, ... Archives of Medical Science 15 (1), 65-71, 2019 | 14 | 2019 |
